Please Wait

Applying Filters...

Bacitracin Zinc
VMF
Table View

Molecular glue degraders: Lilly, AbbVie sign billion-dollar deals; BMS leads with three late-stage drugs

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

Bacitracin Zinc

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

35 API Suppliers, 22 USDMF, 5 CEP/COS, 2 JDMF, 17 NDC API, 1 VMF, 13 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

65 FDF Dossiers, 39 FDA Orange Book, 4 Europe, 16 Canada, 2 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;OPHTHALMIC - 400 UNITS/GM;EQ 3.5MG BASE/GM;10,000 UNITS/GM

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 2 DKSH, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 10 Actylis, 11 BASF, 1 Finar, 5 Gangwal Chemicals, 4 Kerry, 2 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 1 Pluviaendo, 5 Roquette, 7 Seppic

EXCIPIENTS BY APPLICATIONS

19 Topical, 15 Solubilizers, 13 Parenteral, 9 Coating Systems & Additives, 9 Thickeners and Stabilizers, 8 Film Formers & Plasticizers, 6 Emulsifying Agents, 5 Direct Compression, 5 Co-Processed Excipients, 4 Surfactant & Foaming Agents, 4 Fillers, Diluents & Binders, 3 Granulation, 3 Lubricants & Glidants, 2 Taste Masking, 2 Controlled & Modified Release, 2 Rheology Modifiers, 1 API Stability Enhancers